The intermediate conductance Ca 2+ -activated K + (SK4) channel is required for pathological VSMC proliferation. In T lymphocytes, nucleoside diphosphate kinase B (NDPKB) has been implicated in SK4 channel activation. We thus investigated the role of NDPKB in the regulation of SK4 currents (I SK4 ) in proliferating VSMC and neointima formation. Approach and Results-Function and expression of SK4 channels in VSMC from injured mouse carotid arteries were assessed by patch-clamping and real-time polymerase chain reaction. I SK4 was detectable in VSMC from injured but not from uninjured arteries correlating with the occurrence of the proliferative phenotype. Direct application of NDPKB to the membrane of inside-out patches increased I SK4 , whereas NDPKB did not alter currents in VSMC obtained from injured vessels of SK4-deficient mice. The NDPKB-induced increase in I SK4 was prevented by protein histidine phosphatase 1, but not an inactive protein histidine phosphatase 1 mutant indicating that I SK4 is regulated via histidine phosphorylation in proliferating VSMC; moreover, genetic NDPKB ablation reduced I SK4 by 50% suggesting a constitutive activation of I SK4 in proliferating VSMC. In line, neointima formation after wire injury of the carotid artery was substantially reduced in mice deficient in SK4 channels or NDPKB. Conclusions-NDPKB to SK4 signaling is required for neointima formation. Constitutive activation of SK4 by NDPKB in proliferating VSMC suggests that targeting this interaction via, for example, activation of protein histidine phosphatase 1 may provide clinically meaningful effects in vasculoproliferative diseases such as atherosclerosis and post angioplasty restenosis.
T hree types of Ca 2+ -activated potassium channels, 1 large (BK), intermediate (SK4), and small (SK3) conductance Ca 2+ -activated K + channels, have been detected in blood vessels, with preferential expression of BK in vascular smooth muscle cells (VSMCs) and SKs in endothelial cells. 2, 3 VSMCs are phenotypically identified and characterized by expression of smooth muscle-specific marker genes, such as α-smooth muscle actin. Unlike other cell types, VSMCs are not terminally differentiated and can alter their gene expression profile in response to physiological as well as pathophysiological stimuli. During vasculoproliferative diseases, such as atherosclerosis and restenosis, smooth muscle cells undergo phenotypic modulation characterized by suppression of smooth muscle marker genes, increased proliferation and migration. Although SK4 channels are primarily expressed in the endothelium contributing to the control of vascular tone and blood pressure, 4,5 they belong to the genes, the expression of which is significantly enhanced during the phentotypic change of VSMC from the contractile to the synthetic phenotype. Thus, their expression was found to be upregulated in coronary vessels from patients with coronary artery disease. 6 Similarly, in rat carotid artery and pig coronary artery injured by balloon-induced overstretch, SK4 channels were functionally detected in proliferating VSMC. In apolipoprotein E-deficient mice, a genetic model of atherosclerosis, SK4 channel expression was increased not only in VSMC but also in macrophages and T lymphocytes that infiltrated atherosclerotic lesions. 6 Most important, in vivo therapy with the selective SK4 inhibitor TRAM-34 (1-[(2-chlorophenyl) diphenylmethyl]-1H-pyrazole) reduced the development of atherosclerosis in apolipoprotein E-deficient mice, 6 as well as neointimal hyperplasia and stenosis after vascular injury. 7, 8 These data suggest that SK4 channel activity is required for proliferation of VSMC.
SK4 channels are mainly regulated by intracellular Ca 2+ , which binds to the Ca 2+ -binding sites in calmodulin that is constitutively associated with the channel C terminus, thereby increasing channel open probability. 9, 10 Phosphatidylinositol-3-phosphate and its upstream regulator the PI 3 kinase isoform C2β have been also linked to SK4 channel activation. 11, 12 In addition, protein kinase A (PKA) and protein kinase C may enhance or reduce SK4 channel activity depending on cell types. [13] [14] [15] Besides regulation through serine/threonine kinases, nucleoside diphosphate kinase type B (NDPKB) directly phosphorylates SK4 channels at histidine 358 (His358), enhancing channel activity. Together with the counteracting histidine phosphatase 1 (PHPT-1), NDPKB forms a local de/ phosphorylation teeter-totter, fine-tuning channel activity. [16] [17] [18] NDPKs are ubiquitously expressed nucleoside 5′-diphosphate (NDP)/nucleoside 5′-triphosphates (NTP)transphosphorylases. They catalyze the transfer of the γ-phosphate from NTP to NDP by a ping-pong mechanism involving the formation of a high-energy phosphate intermediate on a histidine residue. They are encoded by the NME (nonmetastatic cell) genes, which comprise a family of 10 related genes. Among them, the nonmetastatic cell 1 and 2 proteins, which are frequently named NDPKA and NDPKB, respectively, are responsible for at least 80% of the cellular NDPK activity. They are involved in diverse physiological and pathological processes including proliferation, differentiation, development, and metastasis. 19 However, NDPKB can also act as mammalian protein histidine kinase transferring the phosphate from its high energy phosphate intermediate to histidine residues on other proteins. 18 Besides His358 in SK4 channels, the second well-characterized NDPKB substrate is His266 in the β subunit of heterotrimeric G proteins. 18, 20 Recent evidence from loss of function animal models indicates that the interaction of NDPKB with G proteins as well as with SK4 and TRPV5 (the transient receptor potential cation channel subfamily V member 5) channels are of important physiological relevance. [21] [22] [23] For example, SK4 channel activity was reduced by 50% in T cells of NDPKB-depleted mice and resulted in strongly inhibited cytokine production, 24 pointing to a potential role of NDPKB in inflammation and atherosclerosis. Here, we assessed the role of NDPKB in SK4 channel activation in VSMC and whether NDPKB is required for VSMC proliferation in injured arteries. We found that functional SK4 channels are only detectable in proliferating VSMC isolated from carotid arteries after wire injury and discovered that SK4 channels are constitutively activated by endogenous NDPKB. This activation is obviously required for neointima formation in the injured arteries. Our results demonstrate that NDPKB is an essential component required for the transition of a contractile to a proliferative (synthetic) and proatherosclerotic VSMC phenotype and thus neointima formation.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Functional Expression of SK4 Channels in VSMC From Injured Arteries
To detect the functional role of SK4 channels, whole-cell patch-clamp studies were performed in freshly isolated VSMC from injured and uninjured carotid arteries 2 weeks after operation ( Table I in the online-only Data Supplement). To evoke the whole-cell currents, VSMCs were stimulated through the patch pipette by 300 ms pulses from −100 to +80 mV with increments of 10 mV and a holding potential of −50 mV. Mature VSMC from the uninjured artery exhibited outwardly rectifying K + currents that increased steeply at positive membrane potentials. Application of the selective SK4 channel blocker TRAM-34 had no effect on total current, whereas iberiotoxin, a selective BK channel blocker, inhibited the currents by ≈90% ( Figure 1A ). These data indicate that the BK current (I BK ) is the predominant outward current in mature VSMC from uninjured vessels. At positive membrane potentials, VSMC isolated from the injured artery displayed a smaller total current when compared with VSMC from the uninjured artery. Conversely, at negative membrane potentials total current was larger in VSMC from injured versus uninjured vessels ( Figure 1A and 1B). In VSMC from injured vessels, TRAM-34 significantly inhibited the total current ( Figure 1B ), unmasking the strong contribution of an SK4 current (I SK4 ). At +80 mV, 100 nmol/L TRAM-34 reduced total current from 111.7±21.3 to 77.1±20.4 pA/pF (n=9; P<0.001). Subsequent application of iberiotoxin further inhibited the current to levels seen in VSMC from uninjured vessels (injured, 27.5±1.8 pA/pF; uninjured, 29.1±1.7 pA/pF). Representative original current recordings are shown as insets in Figure 1 . Apamin, a selective blocker for SK1-3 channels, had no significant effect on total current in VSMC from both injured and uninjured vessels ( dependencies. In recordings with Ca 2+ -free intracellular solution, the total current was reduced by ≈85% and TRAM-34 and iberiotoxin failed to inhibit the residual Ca 2+ -independent currents ( Figure IA in the online-only Data Supplement). To eliminate the influence of the driving force on current amplitude, we converted the TRAM-34-sensitive and iberiotoxinsensitive currents from density (pA/pF) to conductance (G m , nS). Plotting G m versus the respective voltages (V m ) allows for the analysis of the voltage dependence of currents. As expected, G m of iberiotoxin (I BK )-sensitive but not of TRAM-34 (I SK4 )-sensitive currents increased with the increment of V m , demonstrating the typical lack of proper voltage dependence of I SK4 ( Figure IB in the online-only Data Supplement). When we dissected the TRAM-34 (I SK4 )-sensitive component from the total current, I SK4 was detectable only in VSMC from injured vessels of wild-type (WT) mice ( Figure 1D ), further validating the exclusive contribution of I SK4 to total VSMC current in injured vessels only. Maximally, I SK4 increased by ≈20-fold. Moreover, endothelial injury reduced I BK by 70% to 80% ( Figure 1C ). In agreement with the electrophysiological data, the level of BK channel mRNA decreased by ≈30% ( Figure 1E ), whereas that of SK4 channel mRNA increased by ≈8-fold ( Figure 1F ) 2 weeks after endothelial injury.
Next, we validated the results obtained in VSMC from injured vessels by repeating the experiments shown in Figure 1 in VSMC from SK4 −/− mice. TRAM-34 failed to inhibit the total current in VSMC regardless whether they were isolated from injured or uninjured vessels of SK4 −/− mice (Figure 2A and 2B). Noteworthy, iberiotoxin exhibited similar effects on the total current in SK4 −/− mice as in WT mice, yielding ≈90% inhibition in VSMC from both injured and uninjured vessels. These data clearly indicate that our model recapitulates the changes in vascular I BK and I SK4 , which are typical for the transition of a contractile to a proliferative VSMC phenotype in atherosclerosis and restenosis.
NDPKB Constitutively Activates SK4 Channels in VSMC From Injured Vessels
To determine whether NDPKB regulates SK4 channels in VSMC from injured vessels, recombinant NDPKB (10 ng/ mL) was applied through patch pipette into the cells and I SK4 was recorded 3 to 5 minutes after the establishment of stable whole-cell currents. Addition of recombinant NDPKB, but not of denatured NDPKB (15 minutes; 95°C), into the patch pipette induced a ≈2-fold enhancement of I SK4 ( Figure 3A ). Concomitant inclusion of PHPT-1 (30 ng/mL), but not the kinase-inactive mutant PHPT-1 (H53A; 30 ng/mL), prevented the stimulatory effect of NDPKB. I SK4 in the presence of PHPT-1 and NDPKB did not differ significantly from the control current. Likewise, I SK4 in the presence of mutated (H53A) PHPT-1 plus NDPKB was similar to that in the presence of NDPKB alone ( Figure 3A) . These findings suggest that histidine phosphorylation is a critical event in the NDPKBinduced I SK4 activation in VSMC from injured vessels. Of note, application of PHPT-1 alone significantly reduced I SK4 in VSMC from injured vessels to ≈42% of the control current (Ctr, 28.7±2.4 pA/pF; PHPT-1, 12.0±2.4 pA/pF; P<0.001), whereas the inactive mutant (H53A) PHPT-1 was without effect (31.3±2.2 pA/pF; Figure 3A ), pointing to a constitutive activation of I SK4 by endogenous NDPKB in VSMC from injured vessels. To directly proof this hypothesis, we recorded I SK4 in VSMC from injured vessel of NDPKB −/− and WT mice. Knockout of NDPKB resulted in ≈50% reduction in basal I SK4 ( Figure 3B ), which is equivalent to the inhibitory effect of PHPT-1 on basal I SK4 in VSMC from injured vessels of WT mice ( Figure 3A ). PHPT-1 applied into VSMC from the injured artery of NDPKB −/− mice did not inhibit I SK4 ( Figure 3B ), further validating the constitutive activation of I SK4 channels by endogenous NDPKB.
To exclude the possibility that the reduction of I SK4 in NDPKB −/− mice resulted from a reduction of SK4 channel expression or inhibition of I SK4 by other means than loss of NDPKB, recombinant NDPKB was applied into VSMC from the injured artery of NDPKB −/− mice. In the presence of exogenous NDPKB, I SK4 in VSMC from NDPKB −/− mice increased to the same level ( Figure 3B ; 81.7±7.3 pA/pF) as in WT mice ( Figure 3A ; 84.5±10.9 pA/pF). In NDPKB −/− mice, the stimulation of I SK4 by exogenous NDPKB was completely suppressed by coapplication of PHPT-1 ( Figure 3B ; 14.7±1.3 pA/pF) to the same level as in WT mice ( Figure 3A; 12.0±2.4 pA/pF) confirming that the reduction of I SK4 in VSMC from NDPKB −/− mice did not result from a reduction of channel number but is because of the loss of NDPKB-dependent channel activation.
Eukaryotic NDPKs can form homo-and heterohexamers. 25, 26 We therefore assessed whether the other isoforms of cytosolic NDPKs, NDPKA and NDPKC, also activate I SK4 . Recombinant NDPKA and NDPKC were applied into VSMC from injured vessels and their effect on I SK4 was determined in comparison with recombinant NDPKB. Neither NDPKA nor NDPKC had a significant effect on I SK4 (Figure 3C) , further supporting the specificity of NDPKB-induced I SK4 activation in VSMC. To further proof the specificity of NDPKB as the exclusive regulator of I SK4 , whole-cell currents were recorded in VSMC from injured vessels of WT mice in the presence of Ca 2+ -free pipette solution and in VSMC from injured vessels of SK4 −/− mice with 0.5 μmol/L Ca 2+ in the pipette solution. I SK4 could not be detected under either condition and application of NDPKB did not exhibit any effect on wholecell currents ( Figure 3D ), excluding significant activation of non-I SK4 currents by NDPKB in VSMC from injured vessels. Current-voltage relationships for the K + currents under all these conditions are shown in Figure II in the online-only Data Supplement.
In addition to the direct activation of I SK4 , NDPKB strongly influences the adenylyl cyclase/cAMP/PKA axis by a direct interaction with heterotrimeric G-protein βγdimers. 23, 27 As SK4 channels are also regulated by the cAMP/ PKA pathway, 28 we studied whether this pathway is involved in the regulation of I SK4 by NDPKB. We treated VSMC from injured vessels with the PKA inhibitor H89 (1 μmol/L) for 30 minutes before applying recombinant NDPKB into the cells. The presence of H89 did not influence the stimulatory effect of NDPKB on I SK4 (Figure 3C ), suggesting that the effect of NDPKB on I SK4 is independent of cAMP/PKA pathway and likely involves a direct interaction between NDPKB and SK4 channels. 16, 17 To test the latter possibility, we recorded single SK4 currents in inside-out patches excised from VSMC from injured vessels and applied recombinant NDPKB through a superfusion pipette directly to the intracellular side of the membrane. Figure 4A shows the original recordings of a representative experiment. An increase in intracellular Ca 2+ concentration from 0.01 to 0.5 μmol/L enhanced the open probability from 0.007 to 0.58. Ten ng/mL recombinant NDPKB further increased NPo by ≈4-fold ( Figure 4B) . A subsequent application of the inactive mutant PHPT-1 (H53A) to NDPKB-activated I SK4 in inside-out patches did not significantly influence the effect of NDPKB on NPo, whereas the addition of active PHPT-1 completely reversed the increase in NPo. Most important, the basal single SK4 current activity decreased by ≈80% (0.52±0.22 before versus 0.1±0.03 after PHPT-1; P<0.01) after histidine dephosphorylation, confirming the whole-cell voltage-clamp results illustrated in Figure 3A . Further analysis revealed that NDPKB increased NPo ( Figure 4B ) without accompanying changes in single channel amplitude ( Figure 4C ) or single channel conductance ( Figure 4D ). Collectively, these electrophysiological data suggest that newly expressed SK4 channels in VSMC from injured arteries are directly activated via histidine phosphorylation by constitutively active NDPKB.
Reduced Neointima Formation in SK4 −/− and NDPKB −/− Mice
Previous work suggests that I SK4 plays an important role in VSMC proliferation. In accordance, inhibition of SK4 channels reduced neointima formation, atherogenesis, and restenosis. [6] [7] [8] 29 As our results indicate that endogenous NDPKB constitutively activates I SK4 in VSMC from injured vessels, we hypothesized that neointima formation should be reduced in injured arteries of both NDPKB −/− and SK4 −/− mice. We therefore histologically assessed injured and uninjured carotid arteries from NDPKB −/− mice by eosin/hematoxylin staining ( Figure 5 ). Four weeks after injury the neointimal area and the ratio of neointimal/medial area were ≈75% to 80% lower in both SK4 −/− and NDPKB −/− mice when compared with WT controls. To identify the proliferating type of cells, we stained for the VSMC marker smooth muscle actin and the proliferation marker Ki67 in the neointima of injured vessels from WT mice. As shown in Figure 6A , many of the smooth muscle actin-expressing cells in the neointima are positive for Ki67, indicating proliferating VSMC. We therefore compared Ki67 staining in the neointima of injured arteries of WT and NDPKB −/− mice ( Figure 6B) . A prominent expression of Ki67 was evident in many cells in the neointima from WT mice. In comparison, the number of Ki67-positive cells in the neointima of NDPKB −/− mice was reduced by >50%. To further confirm that a reduced SK4 activity occurs in all proliferating VSMC from NDPKB −/− mice, we isolated VSMC from single mouse aortas and expanded them in cell culture. 30 Interestingly, VSMC obtained from the aorta of NDPKB −/− mice grew much slower than those isolated from WT mice. As shown in Figure  III in the online-only Data Supplement, these proliferating VSMCs all express SK4. The resulting I SK4 in VSMC obtained from NDPKB −/− mice is however significantly smaller than in VSMC of WT mice. Taken together all these findings support the idea that de novo expression of SK4 channels and their stimulation by constitutively active NDPKB are both required for VSMC proliferation and thus neointima formation in injured arteries.
Discussion
In this study, we investigated the regulation of SK4 channels by NDPKB in proliferative VSMC and the contribution of NDPKB to neointimal hyperplasia in injured mouse carotid arteries. We demonstrate that NDPKB constitutively activates SK4 channels in VSMC and that this increased channel activity correlates with VSMC proliferation and neointima formation in injured vessels.
Comparison With Prior Work
A striking feature of SMCs is their functional plasticity that is important for regulating blood pressure and controlling vascular growth and repair after injury. [31] [32] [33] In mature healthy arteries, the majority of SMCs exist in a fully differentiated contractile state, which is required for physiological regulation of vascular tone. 32, 33 Vessel wall injury induces a switch from the contractile (quiescent) phenotype to a proliferative (motile or synthetic) phenotype, which is accompanied by characteristic alterations in ion channel function: L-type Ca 2+ and BK channels show reduced activity, whereas T-type Ca 2+ channels, transient-receptor potential type-C channels and SK4 channels are upregulated. 7, 31 Specifically, in control VSMC, ≈90% of the total K + Ca current is conducted by I BK with no detectable I SK4 . In VSMC from injured vessels, only ≈60% of the total K + Ca -current was conducted by I BK with a prominent contribution of I SK4 . Our present results confirmed the upregulation of SK4 channels, along with a downregulation of BK channels, in VSMC from injured vessels. The functional identity of SK4 channels in VSMC from injured vessels was validated by their sensitivities to the selective SK4 channel blocker TRAM-34 and Ca 2+ , relative voltage independence, single-channel conductance of expected range (≈28 pS), and absence I SK4 current in SK4 −/− mice.
Previous work showed a unique mechanism of phosphorylation-dependent regulation of SK4 channels. Specifically, in vitro reconstitution experiments as well as data from NDPKB −/− mice demonstrated that SK4 channels are dynamically regulated by the phosphorylation and dephosphorylation of His358 by NDPKB and PHPT-1, respectively. [16] [17] [18] 24 Our present data extend these observations to de novo expressed SK4 channels in proliferating VSMC from carotid arteries. The direct interaction between NDPKB and SK4 channels resulted in enhanced channel open probability. The maximal (seen with saturating amounts of exogenously added NDPKB) as well as the basal activity (seen with saturating amounts of exogenously added PHPT-1) of the de novo expressed SK4 channels in VSMC from injured arteries of WT and NDPKBdeficient mice was virtually identical. These data indicate that the expression of the SK4channel protein itself is not regulated by NDPKB. Remarkably, however, the de novo expression of SK4 channels in VSMC is apparently sufficient to allow a constitutive activation by the endogenously expressed NDPKB. In accordance, PHPT-1 application decreased the SK4 channel activity in VSMC obtained from injured arteries of WT mice to the level observed in VSMC obtained from injured arteries of NDPKB −/− mice.
Potential Significance and Clinical Implications
In VSMC, BK channels function as a negative feedback regulator for Ca 2+ influx, thereby regulating VSMC contraction. Proliferating VSMCs from injured vessels show a reduced contractility which is associated with downregulation of BK channels. The regulation of SK4 channel expression in proliferating VSMC has been linked to many growth factors, for example, fibroblast growth factor, transforming growth factor-β, EGF, epidermal growth factor, and platelet derived growth factor. 6, 7, 34, 35 Extracellular-signal-regulated kinase-and activator protein-1-dependent signaling pathways have been implicated in the regulation of SK4 channels by those factors. 34, 36 The data reported herein indicate that the increase in I SK4 results not only from enhanced channel expression but also from increased channel activity caused by phosphorylation of His358 by endogenous NDPKB. Recent data indicate how these increased I SK4 in proliferating VSMC contribute to the regulation of cell proliferation in atherosclerosis and post angioplasty restenosis. In proliferating VSMC, transient-receptor potential type-C channels (along with T-type Ca 2+ channels), which are activated at more negative membrane potentials (20-40 mV more negative than L-type Ca 2+ channels), are the main channels responsible for Ca 2+ influx. 31 Because of their voltage independency, SK4 channels can maintain their opening even at strong negative membrane potentials. An increase in I SK4, as reported here, will shift the membrane potential to more negative values (hyperpolarization), enhancing the driving force for Ca 2+ influx through transient-receptor potential type-C and/or T-type Ca 2+ channels and leading to an increase in intracellular Ca 2+ concentration. This may trigger the activation of the transcription factor phosphorylated cAMP-response element-binding protein and the subsequent induction of mitogenic immediate early genes such as c-Fos and neuron-derived orphan receptor-1. 37 This potential mechanism is not unique to VSMC, but is also operative in endothelial cells, 15, 38 T-lymphocytes, 16 fibroblasts, 39 and some tumor cell lines. 40 To the best of our knowledge, we provide the first evidence that NDPKB constitutively activates SK4 channels in proliferating VSMC through its previously described protein histidine kinase activity . [16] [17] [18] Importantly, the neointima thickening in the injured carotid arteries of NDPK B −/− mice was reduced to the same extent as in SK4 −/− mice, clearly suggesting that the constitutive activation of SK4 channels by endogenous NDPKB is a key event in VSMC proliferation and neointimal hyperplasia. Most likely, a minimal threshold level for the SK4-mediated K + current exists in VSMC which is required for cell proliferation. This threshold current is only achieved by activation of SK4 channels by endogenous NDPKB in VSMC. In accordance, the expression of the proliferation marker Ki67 was reduced in the neointima of injured vessels of NDPKB −/− mice in comparison with WT mice. Our data thus identify NDPKB as a novel, critical contributor to VSMC proliferation associated with atherosclerosis and post angioplasty restenosis.
The progression of neointima thickening to atherosclerosis does involve not only proliferation and migration of VSMC but also activation of inflammatory cells. [41] [42] [43] Monocytes infiltrate the plaques, differentiate into macrophages, and produce oxidative stress, proteases, and cytokines. 42 Plasmacytoid dendritic cells in plaques activate infiltrating T lymphocytes, which in turn further stimulate macrophages 41, 43 Since in vivo therapy of apolipoprotein E-deficient mice with the selective SK4 channel blocker TRAM-34 significantly reduced the development of atherosclerosis in aortas by suppressing proliferation and migration of VSMC and infiltration of plaques by inflammatory cells (T lymphocytes, macrophages) and by reducing oxidative stress, 6 it is likely that T-lymphocyte activation in mice also requires constitutive activation of SK4 channels by NDPKB. 24 Consistent with this notion, CD4-positive T lymphocytes from NDPKB −/− and SK4 −/− mice show similar profiles of cytokine production and SK4 −/− mice are protected from developing severe colitis in mouse models of inflammatory bowel disease. 22, 24 Therefore, small molecules that inhibit the histidine kinase activity of NDPKB and increase the expression or activity of PHPT-1 might offer new therapeutic options not only for the treatment of post angioplasty restenosis but also for atherosclerosis and other inflammatory diseases. This interpretation is strengthened by the phenotype of the NDPKB −/− mice. They are born at the expected Mendelian frequency with no obvious defects. Besides a moderate cardiac dysfunction 24 and a beginning vasoregression in the retina 44 at higher age, no impairments have been reported. They have a normal life span and thus even the total absence of NDPKB activity seems to be tolerated.
Study Limitations
Here, we did not address the therapeutic potential of specifically targeting the NDPKB/SK4 channel interaction in atherosclerosis. Although this is the first description of the requirement of NDPKB-mediated activation SK4 channels for neointimal hyperplasia, the underlying mechanisms, that is, phosphorylation of His358 in SK4 channels, seem also to occur in other cell types such CD4-positive T lymphocytes. In addition, SK4 channels play an important role in brain function. Therefore, further extensive studies are needed to test whether the specific inhibition of the NDPKB/SK4 channel interaction instead of targeting SK4 channels itself is a viable and a more tissue-specific therapeutic approach for atherosclerosis. Moreover, small molecules specifically inhibiting the catalytic activity of NDPKB or interfering with an interaction of NDPKB with SK4 channels have to be identified. Also, although the role of PHPT-1 as the counteracting phosphatase has been established experimentally, [16] [17] [18] 24 the precise function of this enzyme in a physiological or pathophysiological setting remains enigmatic. 45 Thus, an evaluation of the therapeutic potential of targeting the NDPKB/SK4 or SK4/PHPT-1 interactions in atherosclerosis needs direct extensive investigations in subsequent studies.
